Lapatinib (GW572016) is an inhibitor of ErbB2 and EGFR (IC50=9.2/10.8 nM) with oral activity. Lapatinib has antitumor activity and can be used to treat advanced or metastatic breast cancer with HER2 overexpression.
Molecular Weight:
581.06
CAS Number:
[231277-92-2]
Formula:
C29H26ClFN4O4S
Target:
Autophagy|||Ferroptosis|||EGFR
* VAT and and shipping costs not included. Errors and price changes excepted